Autres langues Stallergenes Greer

Actions

STAGR

GB00BZ21RF93

Temps réel Euronext Paris Autres places de cotation			Varia. 5j.	Varia. 1 janv.
- ^EUR	-.--%		+0,14%	+29,68%

2023	AB Science : Le secteur pharmaceutique signe un accord de branche sur la transition écologique	AO
2023	Nestlé pourrait vendre son traitement contre l'allergie à l'arachide à Stallergenes	CI

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Nestle Reportedly May Sell Peanut Allergy Therapy to Stallergenes	11/07/23
Stallergenes Greer Ltd Initiates European Paediatric Phase III Study with Staloral Birch	25/05/23
Stallergenes Greer Ltd Reports Earnings Results for the Full Year Ended December 31, 2021	06/05/22
Stallergenes Greer Strengthens Precision Medicine Approach in Allergen Immunotherapy with Imperial College London Research Collaboration	17/01/22
Stallergenes Greer and Aptar Pharma Announce Partnership to Develop Novel Connected Device for Allergen Immunotherapy Treatment Delivery	26/10/21
Stallergenes Greer and Alyatec Announce Research Collaboration to Advance Precision Medicine in Allergen Immunotherapy	09/07/21
Stallergenes Greer Ltd Announces Alustal®, Subcutaneous Allergen Immunotherapy Treatment Now Available	24/06/21
Stallergenes Greer and Anergis Report Successful Preclinical Study Results with COP-Virosomes as Second-Generation Allergen Immunotherapy	28/05/20
Stallergenes Greer Announces Submission of A Marketing Authorization Application for STAGR320	04/05/20
Stallergenes Greer plc(ENXTPA:STAGR) dropped from CAC All-Tradable Index	16/05/19
Stallergenes Greer plc(ENXTPA:STAGR) dropped from CAC Small Index	16/05/19
Stallergenes Greer plc(ENXTPA:STAGR) dropped from CAC Small Index	16/05/19
Ares Life Sciences I SARL completed the acquisition of remaining 16.13% stake in Stallergenes Greer plc from a group of shareholders.	16/05/19
Stallergenes Greer plc Reports Unaudited Revenue Results for the First Quarter of 2019; Confirms Earnings Guidance for the Full Year 2019	17/04/19
French healthcare group Stallergenes to be bought out by Bertarelli vehicle	21/03/19
Stallergenes Greer Reports Consolidated Earnings Results for the Year Ended December 31, 2018; Provides Earnings Guidance for the Full Year 2019	21/03/19
Ares Life Sciences I SARL reached an agreement to acquire remaining 16.13% stake in Stallergenes Greer plc from a group of shareholders for approximately €120 million.	21/03/19
Stallergenes Greer plc Announces Unaudited Sales Results for the Full Year Ended December 31, 2018	13/02/19
Stallergenes Greer Announces Management Changes	12/12/18
Stallergenes Greer plc Announces Phase III Trial for its Sublingual Allergy Immunotherapy Tablet STAGR320 to Treat House Dust Mite-Induced Allergic Rhinitis Achieved its Primary Endpoint	20/11/18

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Stallergenes Greer

Actions

STAGR

GB00BZ21RF93

Autres langues

Filtres